2021 - NCI-CONNECTions
-
Five nurses attended a conference to share data from the Natural History Study, which aims to better understand brain and spine tumors and uncover areas for further research.
-
Two physicians share findings from NCI-CONNECT studies in award-winning abstracts.
-
Tom survived a car crash, two bouts of cancer, and an autoimmune disorder. He shares how faith got him through hard times and changed his outlook.
-
Neurosurgeon Dr. John Heiss shares how his ability to provide the best care for rare brain and spine tumor patients depends heavily on teamwork—both inside and outside the operating room.
-
NCI-CONNECT launched a phase 1 clinical trial for people with recurrent rare brain and spine tumors as a first step toward developing a novel drug.
-
A clinical trial investigates immune checkpoint inhibitors with standard treatment in people with aggressive brain cancers to understand the immune system response and improve long-term outcomes.
-
Radiation Oncologist Dr. Kevin Camphausen is helping people with brain and spine tumors by developing drugs that can enhance the impact of radiation treatment.
-
NCI-CONNECT launched an immunotherapy drug trial across its national network of collaborative institutions to reach more people with rare brain and spine tumors.
-
Neuro-oncology providers, researchers, advocates, patients, and care partners gathered virtually to learn and discuss the challenges experienced by people living with brain and spine tumors and develop survivorship care guidelines.
-
Robert shares how surviving a rare brain cancer has given him a new perspective and changed his approach to life, which now includes daily healthy routines and the pursuit of a greater purpose.